Anzeige
Mehr »
Login
Mittwoch, 03.03.2021 Börsentäglich über 12.000 News von 657 internationalen Medien
Fast-Verzehnfachung! Vor neuem “Megaevent”! Neuer Countdown?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PGFW ISIN: CNE100003F01 Ticker-Symbol: CJH 
Tradegate
03.03.21
21:47 Uhr
37,200 Euro
0,000
0,00 %
Branche
Biotechnologie
Aktienmarkt
ASIEN
1-Jahres-Chart
CANSINO BIOLOGICS INC Chart 1 Jahr
5-Tage-Chart
CANSINO BIOLOGICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
37,20038,40021:27
37,20038,00021:50

Aktuelle News zur CANSINO BIOLOGICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SoUPDATE 1-China's CanSino says first vaccines packaged in Mexico will be ready in March19
CANSINO BIOLOGICS Aktie jetzt für 0€ handeln
FrTigermed Supported and Delivered Clinical Study of CanSino COVID-19 Vaccine as Clinical Contract Research Organization208HANGZHOU, China, Feb. 26, 2021 /PRNewswire/ -- China National Medical Products Administration (NMPA) announced on February 25 to grant conditional marketing authorization of Recombinant COVID-19...
► Artikel lesen
FrCanSino Bio (06185) year net loss widens to RMB407.05m16
DoCANSINOBIO-B (06185): INSIDE INFORMATION NMPA'S GRANT OF CONDITIONAL MARKETING AUTHORIZATION FOR RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR)9
DoChina approves two COVID-19 vaccines from Sinopharm's affiliate, CanSino26
DoSinopharm und CanSinoBIO beantragen Zulassung für neue Impfstoffe in China63
24.02.Covid-19 roundup: CanSino submits vaccine to Chinese regulators; AstraZeneca says antibodies show early efficacy against new variants - report15
24.02.UPDATE 3-Sinopharm unit, CanSinoBIO apply in China for COVID-19 vaccines' public use approval25
24.02.UPDATE 2-CanSinoBIO files application in China for COVID-19 vaccine approval4
24.02.UPDATE 1-CanSinoBIO files application in China for COVID-19 vaccine approval7
24.02.CanSinoBIO says filed application in China for COVID-19 vaccine approval3
24.02.CANSINOBIO-B (06185): INSIDE INFORMATION NMPA'S ACCEPTENCE OF APPLICATION FOR CONDITIONAL MARKETING AUTHORIZATION OF RECOMBINANT NOVEL CORONAVIRUS VACCINE (ADENOVIRUS TYPE 5 VECTOR)6
18.02.South Africa Wary of Sputnik, CanSino Shots Because of HIV Risk43
17.02.CANSINOBIO-B (06185): INSIDE INFORMATION RESULTS FORECAST FOR THE YEAR 202054
16.02.CANSINOBIO-B (06185): INSIDE INFORMATION RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) GRANTED EMERGENCY USE AUTHORIZATION IN PAKISTAN50
12.02.UPDATE 2-Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use26
12.02.Pakistan approves Chinese CanSinoBIO COVID vaccine for emergency use9
12.02.UPDATE 1-Pakistan approves Chinese CanSinoBIO COVID-19 vaccine for emergency use - health minister5
12.02.Exclusive: Pakistan approves Chinese CanSinobio COVID-19 vaccine for emergency use - health minister4
11.02.Morgan ups Cansino Biologics (06185) to HK$42043
Seite:  Weiter >>
74 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
4,4,41